Bioassays for TSH Receptor Antibodies: Quo Vadis?

Overview

Journal Eur Thyroid J

Specialties Endocrinology
Oncology

Date 2015 May 12

PMID 25960955

Citations 18

Authors

George J Kahaly

Affiliations

Soon will be listed here.

Citing Articles

Artificial intelligence-based CT-free quantitative thyroid SPECT for thyrotoxicosis: study protocol of a multicentre, prospective, non-inferiority study.

Oh D, Ryoo H, Chung H, Cho S, Kwon K, Kim J BMJ Open. 2024; 14(10):e089552.

PMID: 39401965 PMC: 11475049. DOI: 10.1136/bmjopen-2024-089552.

Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.

Liu T, Zhang X, Long L, Zhou L, Chen J, Li M BMC Endocr Disord. 2022; 22(1):218.

PMID: 36045442 PMC: 9429690. DOI: 10.1186/s12902-022-01114-3.

TSH Receptor Antibodies (TRAb) Assay: An Underutilized Test in India.

Jacob J Indian J Endocrinol Metab. 2022; 26(1):1-3.

PMID: 35662755 PMC: 9162263. DOI: 10.4103/2230-8210.343876.

Thyrotropin receptor antibody immunoassays may not be reliable in confirming diagnosis of Painless Thyroiditis.

Sanyal D, Chatterjee S Acta Endocrinol (Buchar). 2021; 16(4):530-534.

PMID: 34084251 PMC: 8126400. DOI: 10.4183/aeb.2020.530.

Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link.

Frommer L, Kahaly G Front Endocrinol (Lausanne). 2021; 12:618213.

PMID: 33776915 PMC: 7988207. DOI: 10.3389/fendo.2021.618213.

References

Bartalena L, Burch H, Burman K, Kahaly G . A 2013 European survey of clinical practice patterns in the management of Graves' disease. Clin Endocrinol (Oxf). 2015; 84(1):115-20. DOI: 10.1111/cen.12688. View

Lytton S, Kahaly G . Bioassays for TSH-receptor autoantibodies: an update. Autoimmun Rev. 2010; 10(2):116-22. DOI: 10.1016/j.autrev.2010.08.018. View

Leschik J, Diana T, Olivo P, Konig J, Krahn U, Li Y . Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. Am J Clin Pathol. 2013; 139(2):192-200. DOI: 10.1309/AJCPZUT7CNUEU7OP. View

Massart C, Sapin R, Gibassier J, Agin A, dHerbomez M . Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy. Clin Chem. 2008; 55(1):183-6. DOI: 10.1373/clinchem.2008.115162. View

Rees Smith B, Sanders J, Evans M, Tagami T, Furmaniak J . TSH receptor - autoantibody interactions. Horm Metab Res. 2009; 41(6):448-55. DOI: 10.1055/s-0029-1220913. View

Schott M, Minich W, Willenberg H, Papewalis C, Seissler J, Feldkamp J . Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease. Horm Metab Res. 2005; 37(12):741-4. DOI: 10.1055/s-2005-921099. View

Morshed S, Latif R, Davies T . Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology. 2008; 150(1):519-29. PMC: 2630889. DOI: 10.1210/en.2008-0878. View

Giuliani C, Cerrone D, Harii N, Thornton M, Kohn L, Dagia N . A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease. J Clin Endocrinol Metab. 2012; 97(7):E1106-15. DOI: 10.1210/jc.2011-2893. View

Lytton S, Ponto K, Kanitz M, Matheis N, Kohn L, Kahaly G . A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab. 2010; 95(5):2123-31. DOI: 10.1210/jc.2009-2470. View

10.

Rapoport B, McLachlan S . The thyrotropin receptor in Graves' disease. Thyroid. 2007; 17(10):911-22. DOI: 10.1089/thy.2007.0170. View

11.

Kamijo K, Murayama H, Uzu T, Togashi K, Olivo P, Kahaly G . Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. Thyroid. 2011; 21(12):1295-9. DOI: 10.1089/thy.2011.0056. View

12.

Diana T, Brown R, Bossowski A, Segni M, Niedziela M, Konig J . Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab. 2014; 99(5):1648-55. DOI: 10.1210/jc.2013-4026. View

13.

Diana T, Kanitz M, Lehmann M, Li Y, Olivo P, Kahaly G . Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies. Thyroid. 2014; 25(2):169-75. DOI: 10.1089/thy.2014.0346. View

14.

Morshed S, Ando T, Latif R, Davies T . Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades. Endocrinology. 2010; 151(11):5537-49. PMC: 2954721. DOI: 10.1210/en.2010-0424. View

15.

McLachlan S, Rapoport B . Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2012; 23(1):14-24. PMC: 3539254. DOI: 10.1089/thy.2012.0374. View

16.

Rapoport B, Chazenbalk G, Jaume J, McLachlan S . The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev. 1998; 19(6):673-716. DOI: 10.1210/edrv.19.6.0352. View

17.

Araki N, Iida M, Amino N, Morita S, Ide A, Nishihara E . Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur Thyroid J. 2015; 4(1):14-9. PMC: 4404900. DOI: 10.1159/000371740. View

18.

Michalek K, Morshed S, Latif R, Davies T . TSH receptor autoantibodies. Autoimmun Rev. 2009; 9(2):113-6. PMC: 3753030. DOI: 10.1016/j.autrev.2009.03.012. View

19.

Ponto K, Kanitz M, Olivo P, Pitz S, Pfeiffer N, Kahaly G . Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy. Ophthalmology. 2011; 118(11):2279-85. DOI: 10.1016/j.ophtha.2011.03.030. View

20.

Giuliani C, Cerrone D, Harii N, Thornton M, Kohn L, Dagia N . A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment. J Clin Endocrinol Metab. 2012; 97(7):E1080-7. DOI: 10.1210/jc.2011-2897. View